Asia Pacific Clinical Laboratory Services Market Introduction and Overview
According to SPER Market Research, the Clinical Laboratory Services Market is estimated to reach USD 332.75 Billion by 2033 with a CAGR of 4.4%.
The report includes an in-depth analysis of the Asia Pacific Clinical Laboratory Services Market, including market size and trends, product mix, applications, and supplier analysis. A clinical laboratory's ability to offer a wide range of services, including patient diagnosis, prevention, treatment, and management, makes it indispensable to any given economy's healthcare system. These services help doctors make judgements about patient care and tailor prescriptions to each patient's needs and condition. Clinical laboratory services depend on state-of-the-art equipment and test kits to minimise human error and produce accurate findings. These days, a number of clinics use computers and software to help patients find out about reporting test findings and getting billed for finished exams.
- July 2021, A research collaboration agreement has been established between ARUP Laboratories, a premier U.S. reference laboratory and a global leader in cutting-edge laboratory research and development, and Deep Bio, a pioneer in artificial intelligence (AI) cancer diagnosis. The company has profited from this partnership in terms of using AI to cancer diagnosis.
- September 2021: The Cobas pure integrated solutions analyzer, which has a more sophisticated system and is especially suited for the nation's many labs and hospitals, was introduced by Roche Diagnostics' Indian branch.
Market Opportunities and Challenges
There exists a substantial opportunity for independent laboratories to flourish in densely populated and developing nations such as India and China. In these regions, where a significant portion of the population lacks access to adequate medical diagnostic facilities, independent laboratories can play a crucial role in addressing the extensive gap in clinical service providers. Consequently, there has been a notable rise in the number of independent laboratories. According to the National Accreditation Board for Testing and Calibration Laboratories (NABL) in India, the count of NABL-accredited medical labs increased from around 6,200 in November 2020 to 6,975 by March 2022, driven by the growing demand for such services across the country.
Insufficient diagnostic testing could potentially impede the market's growth during the projected timeframe. The approvals regulatory framework has long been a significant barrier to the rapid expansion of the biotechnology, pharmaceutical, and medical technology sectors. To guarantee accurate and trustworthy test findings, clinical laboratory services are subject to strict rules and quality control procedures. Smaller laboratories may find it costly and time-consuming to comply with these rules, which could limit their market. The clinical laboratory services market is also confronting a scarcity of skilled laboratory personnel, including pathologists, clinical laboratory scientists, and technicians. The lack of qualified workers presents a serious obstacle to the development and expansion of clinical laboratory services.
Market Competitive Landscape
The major key players in the Asia Pacific Clinical Laboratory Services Market are: Abbott (U.S.), ARUP Laboratories (U.S.), Bioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), Fresenius Medical Care AG and Co. KGaA (Germany), Genoptix, Inc. (U.S.), Healthscope (Australia), Laboratory Corporation of America Holdings (U.S.), Merck KGaA (Germany), NeoGenomics Laboratories (U.S.), OPKO Health, Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Sonic Healthcare Limited (Australia), The Laboratory Glassware Co. (U.S.), and Tulip Diagnostics (P) Ltd. (India), Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Specialty, By Provider, By Service Type, By Application
|
| Regions covered | Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand and rest of Asia-Pacific
|
| Companies Covered | Abbott (U.S.), ARUP Laboratories (U.S.), Bioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), Fresenius Medical Care AG and Co. KGaA (Germany), Genoptix, Inc. (U.S.), Healthscope (Australia), Laboratory Corporation of America Holdings (U.S.), Merck KGaA (Germany), NeoGenomics Laboratories (U.S.), OPKO Health, Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Sonic Healthcare Limited (Australia), The Laboratory Glassware Co. (U.S.), and Tulip Diagnostics (P) Ltd. (India), Others
|
COVID-19 Impact on Asia Pacific Clinical Laboratory Services Market
The COVID-19 pandemic has profoundly influenced the clinical laboratory services business. Global demand for COVID-19 testing, including RT-PCR and antigen tests, has increased dramatically, which has caused testing capacities to grow quickly. The testing volume had to be adjusted, new testing techniques had to be implemented, and prompt results reporting had to be made sure of. Clinical laboratories now offer remote testing and result delivery, and the pandemic has hastened the implementation of telehealth and remote monitoring. Moreover, COVID-19 research and development initiatives have sparked partnerships between labs, educational institutions, and pharmaceutical firms, encouraging creativity and the creation of novel diagnostic techniques and treatment plans.
Key Target Audience:
- Healthcare Providers
- Diagnostic Laboratories
- Physicians and Healthcare Professionals
- Pharmaceutical Companies
- Biotechnology Companies
- Health Insurance Providers
- Clinical Research Organizations (CROs)
- Medical Equipment Manufacturers
- Telehealth and Digital Health Companies
- Others
Our in-depth analysis of the Clinical Laboratory Services Market includes the following segments:
|
By Specialty: |
Clinical Chemistry Testing
Cytology Testing and Genetic Testing
Drugs of Abuse Testing
Hematology Testing
Immunology Testing
Microbiology Testing
|
|
By Provider: |
Hospital-Based Laboratories
Independent and Reference Laboratories
|
|
By Service Type: |
Esoteric Services
Routine Testing Services
|
|
By Application: |
Bioanalytical and Lab Chemistry Services
Cell and Gene Therapy Related Services
Drug Development Related Services
Drug Discovery Related Services
Preclinical and Clinical Trial Related Services
Toxicology Testing Services
Other Clinical Laboratory Services
|
Key Topics Covered in the Report:
- Asia Pacific Clinical Laboratory Services Market Size (FY’2023-FY’2033)
- Overview of Asia Pacific Clinical Laboratory Services Market
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Specialty (Clinical Chemistry Testing, Cytology Testing and Genetic Testing, Drugs of Abuse Testing, Hematology Testing, Immunology Testing, Microbiology Testing)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Provider (Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories, Independent and Reference Laboratories)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Service Type (Esoteric Services and Anatomic Pathology Services, Routine Testing Services)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Application (Bioanalytical and Lab Chemistry Services, Cell and Gene Therapy Related Services, Drug Development Related Services, Drug Discovery Related Services, Preclinical and Clinical Trial Related Services, Toxicology Testing Services, Other Clinical Laboratory Services)
- Statistical Snap of Asia Pacific Clinical Laboratory Services Market
- Expansion Analysis of Asia Pacific Clinical Laboratory Services Market
- Problems and Obstacles in Asia Pacific Clinical Laboratory Services Market
- Competitive Landscape in the Asia Pacific Clinical Laboratory Services Market
- Impact of COVID-19 and Demonetization on Asia Pacific Clinical Laboratory Services Market
- Details on Current Investment in Asia Pacific Clinical Laboratory Services Market
- Competitive Analysis of Asia Pacific Clinical Laboratory Services Market
- Prominent Players in the Asia Pacific Clinical Laboratory Services Market
- SWOT Analysis of Asia Pacific Clinical Laboratory Services Market
- Asia Pacific Clinical Laboratory Services Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Asia Pacific Clinical Laboratory Services Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Asia Pacific Clinical Laboratory Services Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia Pacific Clinical Laboratory Services Market
7. Asia Pacific Clinical Laboratory Services Market, By Specialty (USD Million)
7.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Specialty, 2023-2033
7.2. Clinical Chemistry Testing
7.3. Cytology Testing and Genetic Testing
7.4. Drugs of Abuse Testing
7.5. Hematology Testing
7.6. Immunology Testing
7.7. Microbiology Testing
8. Asia Pacific Clinical Laboratory Services Market, By Provider (USD Million)
8.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Provider, 2023-2033
8.2. Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories
8.3. Independent and Reference Laboratories
9. Asia Pacific Clinical Laboratory Services Market, By Service Type (USD Million)
9.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Service Type, 2023-2033
9.2. Esoteric Services and Anatomic Pathology Services
9.3. Routine Testing Services
10. Asia Pacific Clinical Laboratory Services Market, By Application (USD Million)
10.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Application, 2023-2033
10.2. Bioanalytical and Lab Chemistry Services
10.3. Cell and Gene Therapy Related Services
10.4. Drug Development Related Services
10.5. Drug Discovery Related Services
10.6. Preclinical and Clinical Trial Related Services
10.7. Toxicology Testing Services
10.8. Other Clinical Laboratory Services
11. Asia Pacific Clinical Laboratory Services Market Forecast, 2019-2033 (USD Million)
11.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share
12. Asia Pacific Clinical Laboratory Services Market, By Specialty, 2019-2033 (USD Million)
12.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Specialty (2019-2026)
12.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Specialty (2027-2033)
13. Asia Pacific Clinical Laboratory Services Market, By Provider, 2019-2033 (USD Million)
13.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Provider (2019-2026)
13.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Provider (2027-2033)
14. Asia Pacific Clinical Laboratory Services Market, By Service Type, 2019-2033 (USD Million)
14.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Service Type (2019-2026)
14.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Service Type (2027-2033)
15. Asia Pacific Clinical Laboratory Services Market, By Application, 2019-2033 (USD Million)
15.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Application (2019-2026)
15.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Application (2027-2033)
16. Asia Pacific Clinical Laboratory Services Market, By Region, 2019-2033 (USD Million)
16.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Region (2019-2026)
16.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Region (2027-2033)
16.3. Australia
16.4. China
16.5. India
16.6. Indonesia
16.7. Japan
16.8. Malaysia
16.9. Philippines
16.10. Singapore
16.11. South Korea
16.12. Thailand
16.13. Rest of Asia-Pacific
17. Company Profile
17.1. Abbott
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. ARUP Laboratories
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. Bioscientia Healthcare GmbH
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. Charles River Laboratories
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. Fresenius Medical Care AG and Co. KGaA
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. Genoptix, Inc.
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments
17.7. Healthscope
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments
17.8. Laboratory Corporation of America Holdings
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments
17.9. Merck KGaA
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments
17.10. NeoGenomics Laboratories
17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent developments
17.11. OPKO Health, Inc.
17.11.1. Company details
17.11.2. Financial outlook
17.11.3. Product summary
17.11.4. Recent developments
17.12. QIAGEN
17.12.1. Company details
17.12.2. Financial outlook
17.12.3. Product summary
17.12.4. Recent developments
17.13. Quest Diagnostics Incorporated
17.13.1. Company details
17.13.2. Financial outlook
17.13.3. Product summary
17.13.4. Recent developments
17.14. Siemens Healthcare Private Limited
17.14.1. Company details
17.14.2. Financial outlook
17.14.3. Product summary
17.14.4. Recent developments
17.15. Sonic Healthcare Limited
17.15.1. Company details
17.15.2. Financial outlook
17.15.3. Product summary
17.15.4. Recent developments
17.16. The Laboratory Glassware Co.
17.16.1. Company details
17.16.2. Financial outlook
17.16.3. Product summary
17.16.4. Recent developments
17.17. Tulip Diagnostics (P) Ltd.
17.17.1. Company details
17.17.2. Financial outlook
17.17.3. Product summary
17.17.4. Recent developments
17.18. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope